EcoDrugPlus

Somatostatin Receptor 2

Ensembl ID : ENSPLAG00000009516
Gene Symbol: SSTR2
1 Cross references
192 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSPLAG00000001961
Gene Symbol: SSTR2
3 Cross references
192 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSPLAG00000015193
Gene Symbol: SSTR5
3 Cross references
188 Possible Orthologues:

Somatostatin Receptor Type 5-Like

Ensembl ID : ENSPLAG00000020466
Gene Symbol: LOC106953409
2 Cross references
183 Possible Orthologues:

Sphingosine Kinase 2-Like

Ensembl ID : ENSPLAG00000013423
Gene Symbol: LOC106953505
2 Cross references
199 Possible Orthologues:

Sphingosine Kinase 2-Like

Ensembl ID : ENSPLAG00000008630
Gene Symbol: LOC106957058
2 Cross references
199 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSPLAG00000011600
Gene Symbol: S1PR1
3 Cross references
200 Possible Orthologues:

Spleen Tyrosine Kinase

Ensembl ID : ENSPLAG00000019409
Gene Symbol: SYK
1 Cross references
199 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSPLAG00000015053
Gene Symbol: LOC106934850
3 Cross references
210 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2a

Ensembl ID : ENSPLAG00000019054
Gene Symbol: SRD5A2A
1 Cross references
208 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSPLAG00000004885
Gene Symbol: SOAT1
3 Cross references
210 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSPLAG00000000193
Gene Symbol: TACR1
3 Cross references
181 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).